Physician

Marco A Ramos, M.D.

According to 2025 Medicare claims, Marco Ramos, M.D. (NPI: 1184799918) practices internal medicine in the Bay City, MI market, with the plurality of this provider's patient population coming from Bay, MI. This provider's primary affiliated billing organization is INTEGRATED KIDNEY SERVICES, PLC (NPI: 1154790632; TIN: 474820831) and primary practice location at 48670-2000. Ramos is affiliated with the POM ACO (ACO ID: A1297), McLaren High Performance Network, LLC (ACO ID: A3317), Mosaic ACO (ACO ID: A5033), and Sound Physicians Long Term Care Management, LLC (ACO ID: A5220), participating under the MSSP model.

Ramos' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 303 traditional Medicare patients, billed 1,689 HCPCS/CPT codes, and received $136,762 in Medicare payments. The top billing code was 99223 (Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes). Part D data shows 1,351 prescription claims across 237 beneficiaries totaling $1,141,651 in drug costs, led by Krystexxa (Pegloticase). 2022 DME data shows 40 claims. Open Payments data shows 47 records totaling $963. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $144,170 and ending at $136,762. Concurrently, Part D prescription costs have risen steadily, from $5,219 to $1,141,651. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	658	2,022	$144,170
2016	498	1,375	$93,766
2017	495	1,771	$131,835
2018	486	2,314	$202,676
2019	466	2,310	$190,412
2020	350	2,408	$205,851
2021	421	2,365	$220,455
2022	330	1,455	$134,457
2023	338	1,446	$131,377
2024	303	1,689	$136,762

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	71	146	$5,219
2016	71	171	$8,551
2017	22	58	$6,551
2018	21	67	$1,318
2019	36	120	$8,789
2020	72	327	$35,382
2021	120	398	$44,499
2022	152	537	$267,638
2023	211	953	$517,488
2024	237	1,351	$1,141,651

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	17	$1,586
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	11	$8
2022	N/R	40	$660
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99223	Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes	129	166	$128
99233	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes	68	231	$90
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	143	320	$84
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	108	354	$60
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	125	251	$11

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Krystexxa	Pegloticase	16	224	$456,351
Jynarque	Tolvaptan	13	364	$251,808
Kerendia	Finerenone	127	8,560	$177,180
Farxiga	Dapagliflozin Propanediol	132	9,528	$172,802
Lokelma	Sodium Zirconium Cyclosilicate	20	944	$22,197

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	47	$963	AstraZeneca Pharmaceuticals LP
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Marco A. Ramos, M.D.?

Tedicare shows public-source Medicare data for Marco A. Ramos, M.D. (NPI 1184799918), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Marco A. Ramos, M.D. have ACO affiliation data?

Marco A. Ramos, M.D. is shown with ACO affiliation data for POM ACO (MSSP, ACO ID A1297), McLaren High Performance Network, LLC (MSSP, ACO ID A3317), Mosaic ACO (MSSP, ACO ID A5033), and Sound Physicians Long Term Care Management, LLC (MSSP, ACO ID A5220).

What billing organization is linked to Marco A. Ramos, M.D.?

Marco A. Ramos, M.D. is linked to INTEGRATED KIDNEY SERVICES, PLC (billing NPI 1154790632) in the available physician profile data.

Does Marco A. Ramos, M.D. have Open Payments data?

Marco A. Ramos, M.D. has 47 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.